Analystreport

Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $24.00 price target on the stock.

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com